AMGN
AMGEN INC
NASDAQ · Healthcare · Drug Manufacturers - General · US
$469.05
+1.69%Forward multiples
Based on analyst estimates
- P/E forward
- 19.43x
- P/E 2026E
- 20.17x
- P/E 2027E
- 18.97x
- P/E 2028E
- 17.93x
- P/S forward
- 6.29x
Trailing multiples
Trailing twelve months
- P/E TTM
- 28.92x
- PEG TTM
- 0.59x
- Price / book
- 21.70x
- Price / sales
- 6.65x
- Price / cash flow
- 20.32x
Enterprise value
- Enterprise value
- $296.9B
- EV / sales
- 7.79x
- EV / EBITDA
- 16.85x
- EV / EBIT
- 23.47x
- Market cap
- $253.6B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026